Death (all causes) · adults with renal vasculitis for maintenance therapy
Azathioprine showed no clear difference in death (median compared with cyclophosphamide (moderate certainty).
1 finding from 1 review
Kidney function · adults with renal vasculitis for maintenance therapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Dialysis · adults with renal vasculitis for maintenance therapy
Azathioprine showed no clear difference in dialysis (median compared with cyclophosphamide (moderate certainty).
1 finding from 1 review
Relapse · adults with renal vasculitis for maintenance therapy
Azathioprine showed no clear difference in relapse at 18 months compared with cyclophosphamide (moderate certainty).
2 findings from 1 review
Serious adverse events · adults with renal vasculitis for maintenance therapy
Azathioprine showed no clear difference in serious adverse events compared with cyclophosphamide (moderate certainty).
1 finding from 1 review
Infections · adults with renal vasculitis for maintenance therapy
Azathioprine showed no clear difference in infections compared with cyclophosphamide (moderate certainty).
1 finding from 1 review
Death · adults with renal vasculitis for maintenance therapy
Azathioprine may leads to lower death compared with methotrexate (low certainty).
1 finding from 1 review
Kidney function · adults with renal vasculitis for maintenance therapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Dialysis · adults with renal vasculitis for maintenance therapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse · adults with renal vasculitis for maintenance therapy
Azathioprine showed no clear difference in relapse compared with methotrexate (low certainty).
1 finding from 1 review
Adverse event causing death or study drug discontinuation · adults with renal vasculitis for maintenance therapy
Azathioprine showed no clear difference in adverse events causing death or study drug discontinuation compared with methotrexate (low certainty).
1 finding from 1 review
Severe adverse events · adults with renal vasculitis for maintenance therapy
Azathioprine may leads to lower severe adverse events compared with methotrexate (low certainty).
1 finding from 1 review